Kleiner Perkins Caufield & Byers Launches Two Funds; $600M Technology And Life Science, $200M Pandemic And Bio Defense
The venture capital firm Kleiner Perkins Caufield & Byers said it established two new funds -- a broadly invested $600 million technology and life science fund and a $200 million $200 million Pandemic and Bio Defense Fund.